Health technology assessment (HTA) agency NICE has finalised its guidance on Amarin's Vazkepa, clearing the path for GPs to start prescribing the drug in up to 425,000 NHS patients at high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback